Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks-Reference-Cited by-同舟云学术

Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks

Published:2005-01 Issue:1 Volume:6 Page:13-20
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Paton NI,Aboulhab J

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2005.00259.x/fullpdf

Reference29 articles.

1. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine

2. Inhibition of Human Immunodeficiency Virus Type 1 Replication by Hydroxychloroquine in T Cells and Monocytes

3. Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy.

4. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy

5. Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Much ado about nothing? Discrepancy between the available data on the antiviral effect of hydroxychloroquine in March 2020 and its inclusion in COVID-19 clinical trials and outpatient prescriptions;Public Health;2023-12

2. A comprehensive study of immune function and immunophenotyping of white blood cells from β‐thalassaemia/ HbE patients on hydroxyurea supports the safety of the drug;British Journal of Haematology;2022-10-11

3. Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2;Pharmaceutics;2022-04-17

4. Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role;ASSAY and Drug Development Technologies;2022-01-01

5. Novel Antiviral Strategies Against Emerging Arbovirus Infections;New Drug Development for Known and Emerging Viruses;2021-12-03